secwatch.observer — SEC 8-K summary
======================================

Issuer:     Karyopharm Therapeutics Inc. (KPTI)
CIK:        0001503802
Form:       8-K
Filed at:   2022-03-28T23:59:59+00:00
Accession:  0001193125-22-086854
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Karyopharm director Michael G. Kauffman resigns effective March 22, 2022
------------------------------------------------------------------------

- Michael G. Kauffman, M.D., Ph.D. resigned from the Board of Directors effective immediately.
- Resignation is not due to any disagreement with the Company's operations, policies or practices.
- No replacement for the departing director has been announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1503802/000119312522086854/0001193125-22-086854-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1503802/000119312522086854/d290356d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-086854

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer